当前位置：
X-MOL 学术
›
Biomed. Chromatogr.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Method development and validation for simultaneous determination of ebastine and its active metabolite carebastine in human plasma by liquid chromatography-tandem mass spectrometry and its application to a clinical pharmacokinetic study in healthy Chinese volunteers.
Biomedical Chromatography ( IF 1.8 ) Pub Date : 2020-05-25 , DOI: 10.1002/bmc.4904 Margaret Phiri 1, 2 , Duo Li 1 , Tengfei Li 1 , Shunli Ji 1 , Tang Ling 1, 2 , Xianjing Li 1, 2 , Huaye Gao 1, 2 , Li Ding 1, 2 , Chang Shu 1
Biomedical Chromatography ( IF 1.8 ) Pub Date : 2020-05-25 , DOI: 10.1002/bmc.4904 Margaret Phiri 1, 2 , Duo Li 1 , Tengfei Li 1 , Shunli Ji 1 , Tang Ling 1, 2 , Xianjing Li 1, 2 , Huaye Gao 1, 2 , Li Ding 1, 2 , Chang Shu 1
Affiliation
A simple LC–tandem mass spectrometry (MS/MS) method to determine ebastine and carebastine (active metabolite) in human plasma was developed and validated. Analytes and internal standards were precipitated by protein precipitation and separated on Synergi Hydro‐RP 80A column (4 μm, 50 mm × 2.0 mm; Phenomenex) by gradient elution with mobile phase A comprising 0.1% formic acid in 5 mm ammonium acetate (NH4Ac) and B comprising 100% methanol at a flow rate 0.4 mL/min. Ions were detected in positive multiple reaction monitoring mode, and they exhibited linearity over concentration range 0.01–8.0 and 1.00–300 ng/mL for ebastine and carebastine, respectively. A clinical pharmacokinetic study was conducted in healthy Chinese volunteers under fasting and fed conditions after a single oral administration of 10 mg ebastine. The maximum plasma concentration (Cmax), time to Cmax (Tmax) and elimination half‐life for ebastine were 0.679 ± 0.762 ng/mL, 1.67 ± 1.43 h and 7.86 ± 6.18 h, respectively, whereas these for carebastine were 143 ± 68.4 ng/mL, 5.00 ± 2.00 h and 17.4 ± 4.97 h, respectively under fasting conditions; the corresponding values under fed conditions were 4.13 ± 2.53 ng/mL, 3.18 ± 1.09 h and 21.6 ± 7.77 h for ebastine and 176 ± 68.4 ng/mL, 6.14 ± 2.0 h and 20.0 ± 4.97 h for carebastine.
更新日期：2020-05-25
京公网安备 11010802027423号